These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31413559)

  • 1. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort.
    Le LAK; Johannessen A; Hardie JA; Johansen OE; Gulsvik A; Vikse BE; Bakke P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1639-1655. PubMed ID: 31413559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization.
    Johannessen A; Nilsen RM; Storebø M; Gulsvik A; Eagan T; Bakke P
    Am J Respir Crit Care Med; 2013 Jul; 188(1):51-9. PubMed ID: 23590268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.
    Han MZ; Hsiue TR; Tsai SH; Huang TH; Liao XM; Chen CZ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3425-3433. PubMed ID: 30425472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Hsu CH; Hsiue TR
    J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Hospitalization and Mortality in Patients with Chronic Obstructive Pulmonary Disease with the New Global Initiative for Chronic Obstructive Lung Disease 2023 Group Classification: A Prospective Cohort and a Retrospective Analysis.
    Cheng W; Zhou A; Zeng Y; Lin L; Song Q; Liu C; Zhou Z; Peng Y; Yang M; Yang L; Chen Y; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2341-2352. PubMed ID: 37908629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.
    Leivseth L; Brumpton BM; Nilsen TI; Mai XM; Johnsen R; Langhammer A
    Thorax; 2013 Oct; 68(10):914-21. PubMed ID: 23611880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOLD Classifications, COPD Hospitalization, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: The HUNT Study.
    Bhatta L; Leivseth L; Mai XM; Henriksen AH; Carslake D; Chen Y; Langhammer A; Brumpton BM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():225-233. PubMed ID: 32099347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.
    de Torres JP; Casanova C; Marín JM; Pinto-Plata V; Divo M; Zulueta JJ; Berto J; Zagaceta J; Sanchez-Salcedo P; Cabrera C; Carrizo S; Cote C; Celli BR
    Thorax; 2014 Sep; 69(9):799-804. PubMed ID: 24969641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the GOLD 2017 classification in the prediction of mortality and respiratory hospitalization in patients with chronic obstructive pulmonary disease.
    Lee SJ; Yun SS; Ju S; You JW; Cho YJ; Jeong YY; Kim JY; Kim HC; Lee JD
    Int J Chron Obstruct Pulmon Dis; 2019; 14():911-919. PubMed ID: 31118600
    [No Abstract]   [Full Text] [Related]  

  • 11. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
    Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.
    Tejero E; Prats E; Casitas R; Galera R; Pardo P; Gavilán A; Martínez-Cerón E; Cubillos-Zapata C; Del Peso L; García-Río F
    Am J Respir Crit Care Med; 2017 Aug; 196(3):298-305. PubMed ID: 28306326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the 2007 and 2011 GOLD Classifications as Predictors of all-Cause Mortality and Morbidity in COPD.
    Brusse-Keizer M; Klatte M; Zuur-Telgen M; Koehorst-Ter Huurne K; van der Palen J; VanderValk P
    COPD; 2017 Feb; 14(1):7-14. PubMed ID: 27442500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease.
    Pandey AK; Verma AK; Singh A; Kant S; Dixit RK; Chaudhary SC; Bajpai J; Prakash V; Verma UP
    Cureus; 2022 Dec; 14(12):e32116. PubMed ID: 36601200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
    Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
    Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Accuracy of Three COPD Classification Systems in Relation to Long-Term Mortality of COPD Patients: A Prospective Multicenter Study.
    Plutinsky M; Brat K; Svoboda M; Zatloukal J; Popelkova P; Koblizek V
    Lung; 2019 Apr; 197(2):173-179. PubMed ID: 30694380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort.
    Çolak Y; Nordestgaard BG; Vestbo J; Lange P; Afzal S
    Thorax; 2020 Nov; 75(11):944-954. PubMed ID: 32820083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.